
9.81 Delayed Data As of Dec 08 | ![]() Today’s Change | 7.60 Today|||52-Week Range 28.25 | -33.54% Year-to-Date |
Previous close | 9.64 |
Today’s open | 9.69 |
Day’s range | 9.62 - 9.89 |
Volume | 484,133 |
Average volume (3 months) | 623,945 |
Market cap | $343.8M |
Earnings growth (last year) | +25.72% |
Earnings growth (this year) | +15.95% |
Earnings growth (next 5 years) | +15.00% |
Revenue growth (last year) | +22.24% |
P/E ratio | NM |
Price/Sales | 4.58 |
Price/Book | 10.58 |
Today’s change | Today’s % change | |
---|---|---|
ABUSArbutus Biopharma Co... | -0.01 | -0.48% |
---- | ||
ORTXOrchard Therapeutics... | -0.01 | -0.06% |
---- |
Next reporting date | March 7, 2024 |
EPS forecast (this quarter) | $0.18 |
Annual revenue (last year) | $88.6M |
Annual profit (last year) | -$14.1M |
Net profit margin | -15.90% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Nashville, Tennessee |